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al-Acid glycoprotein (AGP) was purified to homogeneity by a 3-step procedure using pseudo-ligand 
affinity chromatography on immobilized Cibacron blue F3GA, Procion red HE3B, and preparative 
column isoelectric focusing. The overall yield of the combined techniques was 88%. Analysis of the 
purified AGP by lectin affinity chromatography on immobilized Con A and immunoafflno- 
electrophoresis indicated that the most acidic form did not interact with the lectin, while the two more basic 
fractions possessed ifferent affinities for Con A. In addition, 3 different populations of AGP were clearly 
separated by Con A affinity chromatography. 
al-Acid glycoprotem Orosomucord Cibacron blue Procion red 
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1. INTRODUCTION 
al-Acid glycoprotein (AGP) is normally present 
in human plasma at concentrations of 
0.50-l ‘00 g/l. These values may increase 2-4-fold 
during acute in~~rnato~ states [1,2]. This 
response is typical of the class of plasma proteins 
known as acute phase reactants [3,4]. AGP is a 
41-kDa plasma protein which is produced by the 
hepatocytes [5,6]. It is characterized among the 
other plasma proteins by its unusually high car- 
bohydrate content (42%) which includes a large 
number of sialyl residues, its very acidic isoelectric 
point(s) (~1 2.7-3.5), and its microheterogene- 
ity which has been attributed to different 
sialyl-galactosyl linkages [2,7-lo]. In addition, a 
large number of amino acid substitutions, and a 
significant degree of homology with im- 
munoglobuhn have been reported [2,5]. Previous 
studies have provided evidence that AGP is 
capable of inhibiting platelet aggregation [ 11,121, 
phagocytosis of Escherichia coli and Staphylococ- 
cus aureus by neutrop~s 1131, and blastogenic 
transformation of human lymphocytes in the 
presence ofphytohaemagglutinin [14]. In addition, 
AGP binds a number of therapeutic agents, and 
the increased plasma levels of AGP result in in- 
creased binding of a number of therapeutic drugs 
basically charged such as heparin, propranolol, 
chlorpromazine [ 151. 
Most of the procedures for the isolation of 
human AGP use as a first step removal of most 
plasma protein by precipitation at pH 5, followed 
by submitting the supernatant toa combination of 
chromatographic procedures on DEAE- and/or 
CM-cellulose. Gel filtration chromatography on 
Sephadex G-100 is used as a final step [2]. Pseudo- 
Iigand affinity chromatography on immobilised 
Cibacron blue F3-GA has been recently developed 
as a first step for protein fractionation, which 
prevents apossible alteration due to salt precipita- 
tion 1161. We here used pseudo-af~~ty chroma- 
tography on both immobilized Cibacron blue 
F3-GA and Procion red HA3B in combination 
with preparative isoelectric focusing (IEF) to 
isolate AGP from normal human plasma. Par- 
ticular emphasis was placed on analysis of the in- 
teraction of the carbohydrates of AGP obtained 
from preparative IEF chromatography with free 
concanavalin A (Con A) using immunoaffino- 
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electrophoresis and chromatography on im- 
mobilized Con A. 
2. MATERIALS AND METHODS 
Human plasma was obtained from healthy 
blood donors with their informed consent. After 
centrifugation at 500 x g for 15 min, sodium azide 
(final concentration 0.2%) and soybean trypsin in- 
hibitor (50 mg/dl) were added. The plasma was 
kept frozen at -20°C until used. Forty ml of 
plasma were dialyzed overnight against 0.03 M 
sodium phosphate (pH 7.0, Z = 0.05). A column 
(100 x 2.5 cm) was filled with Affigel blue (a gift 
from Biorad, Richmond, CA) equilibrated in the 
same buffer. The bed volume of settled gel 
represented 400 ml. After application of the sam- 
ple, the column was washed first with 2.5 bed vols 
of the equilibration buffer, then with a linear salt 
gradient from 0 to 1 .O M NaCl in the equilibration 
buffer. The column was run at room temperature, 
at a flow rate of 30 ml/h, and 4.8-ml fractions 
were collected at 4°C. The fractions containing 
AGP were pooled, concentrated under nitrogen 
pressure by ultrafiltration on an Amicon PM10 
filter (Amicon, Denver, CO) and then dialyzed 
overnight against acetic acid-sodium acetate buf- 
fer (pH 5.8, Z = 0.05). A column (20 x 1.6 cm) was 
filled with Red Sepharose CL-6B (a gift from 
Pharmacia, Piscataway, NJ) equilibrated with the 
same buffer. After application of the sample, the 
column was washed first with 2 bed vols of 
equilibration buffer, then with a linear salt gra- 
dient from 0 to 1.0 M NaCl in the equilibration 
buffer. The column was run at room temperature 
at a flow rate of 30 ml/h. The fractions containing 
AGP were desalted by overnight dialysis against 
1% glycine (w/v), and applied on a preparative 
IEF column (LKB 8100 type 110 ml column, LKB, 
Orsay, France). The final concentration of the car- 
rier ampholytes was 2% (w/v) (Pharmalyte, pH 
range 2.5-5, Pharmacia), and stabilized in a 
5-50% linear sucrose gradient. The electrode solu- 
tions were prepared as in [ 151, and the elec- 
trophoresis performed at 4°C at constant power 
(7 W), and limiting voltage preset at 1700 V. Frac- 
tions were collected from the bottom of the col- 
umn at a flow rate of 10 ml/h. The elution profile 
of each chromatography run was monitored at 
280 nm, and specific determination of proteins 
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was performed by fused rocket immunoelec- 
trophoresis using antisera against human AGP and 
whole human serum. Immunoaffino-electrophore- 
sis, immunoelectrophoresis, fused rocket immuno- 
electrophoresis, SDS-polyacrylamide gel electro- 
phoresis (SDS-PAGE), total protein measurement 
and Con A affinity chromatography were carried 
out according to standard procedures [ 18-221. 
3. RESULTS AND DISCUSSION 
A combination of pseudo-affinity chromato- 
graphy on immobilized Cibacron blue F3GA and 
Procion red HE3B and preparative IEF is propos- 
ed for the purification of AGP. Fig.1 shows the 
elution profiles of the 3 chromatographic steps. 
AGP is eluted in the non-bound fraction, from the 
Cibacron blue column together with cul-antitrypsin 
(AlAT), prealbumin, a2-HS glycoprotein, group- 
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Flg.1. Absorbance at 280 nm of plasma fractions 
obtamed by chromatography on Affigel blue (A), 
Procion red (B) and preparative column IEF (C). (mm n)
Position where AGP was eluted; (....) development of 
salt gradient; (*) development of pH gradient 
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specific component, transferrin, ceruloplasmin, 
IgA, and some IgG [16]. We found that when the 
Red Sepharose was equilibrated with sodium 
acetate buffer (pH 5.8), most of these proteins 
tightly bound on the dye ligand with the exception 
of AGP, AlAT and a trace amount of prealbumin. 
Analysis of the unbound fractions from the Red 
Sepharose column by fused rocket immunoelectro- 
phoresis (fig.2) indicated that AlAT is weakly 
retarded and most of the AGP was eluted in part 
ahead of AlAT. Considering the very acidic pl of 
AGP, these contaminants were easily removed by 
an additional step of preparative IEF (IEF 
column). Fig. 1,3 shows that AGP was eluted in the 
second peak of the elution profile of the IEF 
column. The first peak corresponded to the absor- 
bance of the anodic solution. 
No contaminants could be detected by using a 
series of monospecific antisera against human pro- 
teins, by SDS-PAGE, and immunoelectrophore- 
sis. Determination of the yield by immuno- 
nephelometry is indicated in table 1. 
Frg.2. Fused rocket immunoelectrophoresis of tubes 
lo-50 eluted from Procion red, and developed against 
human err-antrtrypsin (20&ml, A), and human AGP 
(20 yl/ml, B). Gel was 1% agarose (1.5 mm thrck) m 
7.88 mM sodium barbital/l 40 mM barbitaW93.67 mM 
glycme/46.6 mM Trts (pH 8.6). Three 81 of samples 
were applied to the wells. The plates were run overnight 
at 2 V/cm, then pressed, washed twice, dried and 
stained. Anode at the top. 
Fig.3. Fused rocket immunoelectrophoresrs of tubes 
20-81 collected from preparative column IEF. For 
technical details see legend to fig.2. 
The immunoaffino-electrophoresis (fig.4) ap- 
plied to the study of the different fractions con- 
taining AGP separated by the IEF column in- 
dicated that the most acidic subpopulations of 
AGP did not bind Con A. These data indicate that 
the interaction of AGP for Con A parallels the p1 
of the protein and suggests that the sugar con- 
figuration is responsible for the different p1 values 
of the protein. Furthermore, the same fractions 
pooled and applied on an immobilized 
Con A-Sepharose column revealed 3 clearly 
separated AGP populations: Con A tightly bound, 
weakly retarded, and non-reactive. Similar results 
Table 1 
AGP concentration and overall yield after the different 
purification steps 
Material Volume 
(ml) 
g/l Overall 
yield (0700) 
Dialyzed human 
plasma 
Pool of Affigel 
blue fractions 
(tubes 45-80) 
Pool of Procion 
red (tubes 10-25) 
Pool of column 
IEF (tubes 18-44) 
40 1.10 100 
168 0.25 95 
80 0.51 93 
26 1.50 88 
AGP concentration was measured by immuno- 
nephelometry using a protein standard obtamed from 
Hyland Travenol (Derfield, IL) 
81 
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Frg.4. Crossed affinotmmuno-electrophoresis developed against human AGP. (A) Control experiment without lectin, 
(B) with free Con A in the first-dimension gel. The lectin concentration was 0.143 mg Con A per cm’. For other 
technical details see legend to fig.2. 
were observed in [8]. AGP affinity for Con A is 
related to its heteroglycanic structure. As 
demonstrated in [7] and [8] the sugars of AGP ex- 
hibit 5 different structures: biantennary chain, 
triantennary chain, triantennary chain plus fucose, 
tetra-antennary, tetra-antennary plus fucose. In- 
creasing complexity in the glycanic structure of 
AGP results in decreasing affinity for Con A. 
Our purification procedure appears to have 
several advantages over previously reported tech- 
niques. First, it does not involve denaturing steps 
such as acidic precipitation and/or exposure to 
strongly denaturing agents. The overall yield is 
about 88%. The chromatographic gels used are 
commercially available. In addition, it provides an 
AGP without apparent alteration of the car- 
bohydrate structure as demonstrated by affinity 
techniques on Con A. This is important in view of 
the biological role suggested for this protein as 
drug-carrier [15] and modulator of the immune 
response [1,2,12,23]. The understanding of the 
relationships between the structure and im- 
munomodulative functions of AGP is of great in- 
terest. The carbohydrate moieties of AGP may 
play a key role in its biological functions. The 
AGP prepared according to our procedure may 
provide a reliable native material to investigate its 
immunoregulatory role as suggested by authors in 
[23]. These authors particularly mention the 
enhanced potency of the agalacto/asialo 
derivatives in suppressing a number of immune 
functions of mouse spleen cells in vitro. Finally, 
this purification procedure illustrates the versatili- 
82 
ty of pseudo-ligand affinity chromatography for 
protein purification under close to physiological 
conditions. 
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